ODT Odonate Therapeutics Inc.

Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.

$17.66  -0.22 (-1.23%)
As of 03/05/2021 15:59:26 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
12/07/2017
38,603,588
322,656
$690,232,153
0.00%
SEC Edgar Online
10-Q
10-K
676079106
US6760791060
BD1KGM3

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
5.06
0.00
-92.81%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy